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Abstract
Small conductance calcium-activated potassium channels (KCa2.1,2.2,2.3) are blocked with high affinity by both peptide
toxins (e.g. apamin) and small molecule blockers (e.g. UCL 1848). In electrophysiological experiments, apamin shows
subtype selectivity with IC50so f,100 pM and ,1 nM for block KCa2.2 and KCa2.3 respectively. In binding studies, however,
apamin appears not to discriminate between KCa2.2 and 2.3 and is reported to have a significantly higher (,20–200-fold)
affinity (,5 pM). This discrepancy between binding and block has been suggested to reflect an unusual mode of action of
apamin. However, these binding and electrophysiological block experiments have not been conducted in the same ionic
conditions, so it is also possible that the discrepancy arises simply because of differences in experimental conditions. We
have now examined this latter possibility. Thus, we measured
125I-apamin binding to intact HEK 293 cells expressing KCa2
channels under the same ionic conditions (i.e. normal physiological conditions) that we also used for current block
measurements. We find that binding and block experiments agree well if the same ionic conditions are used. Further, the
binding of apamin and other blockers showed subtype selectivity when measured in normal physiological solutions
(e.g.
125I-apamin bound to KCa2.2 with KL 91640 pM and to KCa2.3 with KL 7116126 pM, while inhibiting KCa2.2 current at
IC50 10362 pM). We also examined KCa2 channel block in Ca
2+ and Mg
2+ free solutions that mimic conditions reported in
the literature for binding experiments. Under these (non-physiological) conditions the IC50 for apamin block of KCa2.2 was
reduced to 2063 pM. Our results therefore suggest that the apparent discrepancy between blocking and binding reported
in the literature can be largely accounted for by the use of non-physiological ionic conditions in binding experiments.
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Introduction
Small conductance Ca
2+-activated potassium channels (SK or
KCa2) are widely expressed in vertebrates and have a role in the
function of both excitable and inexcitable tissues [1,2]. Native
KCa2 channels were first defined by their sensitivity to intracellular
Ca
2+, low unitary conductance (5–10 pS), lack of voltage
dependence and sensitivity to block by the bee venom toxin
apamin [3,4]. Apamin is an 18 amino acid peptide that has since
been used in many functional studies and also, in its mono-
iodinated form, as a radio-labelled ligand [see e.g. 5,6]. A number
of other highly potent and selective toxins have also been identified
that target KCa2 channels [7] as well as several potent small
molecule inhibitors such as UCL1684 [8] and UCL1848 ([9],see
[10] for an excellent review).
Cloning studies have shown that KCa2 channels are encoded by
a family of three genes (KCNN1-3) each of which forms a channel
alpha subunit (SK1-3 or KCa2.1, 2.2, 2.3) [11]. Functional
channels are comprised of four alpha subunits each of which
constitutively binds calmodulin, which is responsible for channel
gating by Ca
2+ [12]. Although there is a high degree of sequence
identity between all three members of this family, they show
important functional differences. In fact, while the rat and human
KCa2.2 and KCa2.3 subunits can form functional homomeric
channels, only the human (and not the rat) isoform of KCa2.1 is
able to do so. Indeed, in both rat and mouse, functional expression
of KCa2.1 channels appears to rely on co-assembly with KCa2.2
subunits, via the formation of functional heteromeric channels
[13]. Another notable difference between the three KCa2 channel
subunits lies in the susceptibility of the channels they form to block
by peptide toxins and small molecule inhibitors. For example,
apamin has been reported to block the current carried by KCa2.2
channels with an IC50 of <100 pM while KCa2.3 channels were
less sensitive (IC50 <1 nM) [11]. Human KCa2.1 channels, when
expressed in mammalian cell lines, are even less sensitive to
apamin with an IC50 of ,3–12 nM [14,15]. However, a different
picture emerges from some direct studies of the binding of
125I-
apamin to heterologously expressed KCa2 channels. These suggest
that apamin binds to all the KCa2 subtypes with very high affinity
(in the low picomolar range) and shows a much smaller degree of
selectivity. For example, Finlayson et al. [16] showed that in
saturation binding experiments
125I-apamin bound with KL values
of 6 pM, 8 pM and 270 pM for KCa2.2, KCa2.3 and KCa2.1
respectively. Similarly, Lamy et al. [17] reported a value of 6 pM
for both KCa2.2 and KCa2.3. Thus, in these experiments, not only
did apamin fail to show appreciable selectivity between KCa2.2
and KCa2.3, as seen in functional studies, but the absolute affinity
of apamin for all subtypes was much higher (,20–200-fold) than
would have been expected from the concentrations observed to
block KCa2 channels in intact cells. One suggestion is that these
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view that has quickly gained favour (see Adelman et al. [1] for a
review). However, it is possible that such discrepancies simply
reflect differing experimental conditions. The aim of the present
work was to examine this second possibility by comparing KCa2
channel binding and functional inhibition under near-identical
experimental conditions.
Methods
Radio-ligand binding studies with
125I-apamin
Radio-ligand binding studies were conducted using HEK 293
cell lines stably expressing KCa2.2 or KCa2.3. The cells were
cultured in DMEM supplemented with 10% foetal calf serum,
2 mM L-glutamine, penicillin (200 units ml
–1) and streptomycin
(100 mgm l
–1) in T500 flasks (Nunc). When confluent, these cells
were harvested mechanically (to avoid the use of trypsin) into
Ca
2+/Mg
2+ free HBSS. The cells were centrifuged at 50 g for
2 min, resuspended in DMEM at a density of approximately
2.5610
6 cells ml
–1 and stored at 4uC until used (,2 hr). Cell
density was estimated using a haemocytometer.
Routinely, incubations were performed in a total volume of
250 ml comprising 100 ml cell suspension (,250000 cells), 100 ml
125I-apamin and 50 ml displacing agent or incubation medium.
The incubation medium contained (in mM) NaCl 140, KCl 5,
MgCl2 1, CaCl2 2, glucose 10 and HEPES 10. The pH was
adjusted to 7.4 with 1 M NaOH. Non-specific binding was
estimated in the presence of 100 nM UCL 1848, a potent KCa2
channel blocker which causes maximal inhibition at this concen-
tration (see Hosseini et al. [18], Benton et al.[13]). Measurements
for each test were performed in triplicate. Separation of cells from
unbound ligand was achieved by rapid filtration through What-
man GF/B filters pre-treated with 0.3% v/v polyethyleneimine
using a Skatron AS harvester. The quantity of labelled apamin
bound was measured using a calibrated c counter (LKB 1275) and
expressed as fmol label/10
6 cells. All binding experiments were
conducted at room temperature (20–25uC).
Saturation binding experiments
In order to establish a suitable incubation period for equilibrium
binding studies we measured the time course of association of
125I-
apamin to KCa2.2 and KCa2.3 expressing HEK cells by incubating
the cells with a low concentration of
125I-apamin (20 pM and
60 pM for KCa2.2 and KCa2.3 respectively). This established a
10 minute incubation as appropriate (see results). In order to
estimate the maximum total (specific) binding (Bmax) and the
equilibrium dissociation constant (KL) the data for total binding was
fitted to an equation of the form:Btot~Bmax
½L 
KLz½L 
za½L where
Btot is the total label bound, [L] is the concentration of free ligand
and ‘a’ is a constant associated with non-specific binding (Bns),
obtained by simultaneously fitting the data for non-specific binding
to a straight line:
Bns~a½L 
Competition binding experiments
The ability of test compounds to inhibit
125I-apamin binding
was measured in the presence of 20–60 pM
125I-apamin with or
without the test compound. In every experiment each concentra-
tion of inhibitor was tested in triplicate and the data presented
represents the mean of at least two separate experiments.
Inhibition curves were fitted by a variant of Hill-Langmuir
equation:
BI~100:
IC50
IC50z½I 
where BI is the specific binding of label in the presence of inhibitor
as a percentage of the binding in its absence. Estimates of Ki were
obtained using the Cheng-Prussoff correction taking estimates of
KL from the saturation binding studies.
Electrophysiology
For electrophysiology, wild type and stably transfected HEK
cells were plated in 35 mm dishes. In most experiments KCa2.2
was transiently expressed in HEK 293 cells. Transient transfection
was achieved using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. Briefly, 2 mg channel plasmid and
1 mg QBI (QBiogene), which expresses GFP, was mixed with 3 mg
Lipofectamine 2000 and added to each 35 mm dish. GFP
expressing cells were identified by epi-fluorescence. Conventional
whole cell recordings were made using an EPC9 amplifier
controlled by Pulse software (Heka). Data were filtered at 1 kHz
and acquired at 5 kHz. Borosilicate glass patch pipettes (2–5 MV)
were coated with Sylgard resin, fire polished and filled with a
solution containing (in mM): KCl 140, HEPES 10, K2HEDTA 5,
and either 1.2 CaCl2 (free Ca
2+ =1mM) or no added Ca
2+ (free
Ca
2+ ,10 nM). The pH was adjusted to 7.2 with 1 M KOH. Free
Ca
2+ concentrations were calculated using the REACT program
(G.L. Smith, University of Glasgow) and stability constants for
HEDTA published in Martell and Smith [19]. Except where
stated the extracellular solution was the same as the incubation
medium used in binding experiments. As with binding studies all
experiments were performed at room temperature (20–25uC).
Routinely, cells were held at 280 mV and 100 ms test pulses
applied to potentials between 2120 mV and 40 mV. HEK 293
cells possess a small endogenous voltage-dependent outward
current (see Fig. 1) which is activated at potentials positive to
0 mV. In order to avoid contamination of KCa2 current by the
endogenous currents, inhibition by blocking agents was measured
at 220 mV. In practise it was found that under these cossnditions
it was possible to obtain .90% inhibition of the current with KCa2
channel blockers.
Concentration-inhibition curves were fitted by a variant of the
Hill equation with the form:
y
100
~
IC50
n
IC50
nz½B 
n
where y is the current in the presence of blocker at concentration
[B] expressed as a percentage of control and n is the Hill
coefficient.
Immunohistochemistry
HEK 293 cells were plated on glass coverslips and transiently
transfected with either KCa2.2 and GFP or KCa2.3 together with
GFP, as described above. Cultures were then stained using rabbit
polyclonal antibodies against KCa2.2 or KCa2.3 as previously
described [20]. Briefly, cells were first washed in phosphate
buffered saline (PBS; composition (mM): NaCl 136.9, KCl 2.7,
Na2HPO4 9.2, KH2PO4 1.8, pH to 7.2 with HCl) and fixed in
PBS containing 4% paraformaldehyde for 10 min. After rehydra-
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followed by a 5 min wash in PBS. Next the cells were incubated in
an antibody blocking solution (2% horse serum, 2% BSA in PBS)
for 1 hr and then incubated in the appropriate primary antibody
for 4 hr. The 4 hr incubation was followed by three washes in a
PBS solution containing 1% Tween-20. The cells were then
incubated in a solution containing a TRITC labelled goat anti-
rabbit secondary antibody for 1 hr. The cells finally underwent
three washes in PBS (containing 1% Tween-20) and the coverslips
were mounted onto clean glass slides using an antifade mount
(Vectashield, Vector Laboratories Incorporated).
Materials
Rat KCa2.2, subcloned into pTracer and a HEK 293 cell line
stably expressing KCa2.2 were kindly provided by Professor
L.Kaczmarek, Yale University and Professor William Joiner,
UCSD. UCL 1684 and UCL 1848 were prepared in the
laboratory of Professor. C.R. Ganellin, UCL. Tissue culture
reagents and Lipofectamine 2000 were purchased from Invitro-
gen. Apamin, gallamine, dequalinium, horse serum, bovine serum
albumen and TRITC labelled goat anti-rabbit IgG were from
Sigma. A stable HEK 293 KCa2.3 cell line was created using
zeocin selection following transfection with the rat KCa2.3
subcloned into the pcDNA3.1 zeo plasmid (Invitrogen). [
125I]
mono-iodoapamin (
125I-apamin) was supplied by New England
Nuclear.
Results
Wild type HEK 293 cells do not express KCa2 channels
In order to rule out the possibility that our results might be
complicated by the endogenous expression of KCa2 channels in
HEK 293 cells, we performed a number of control experiments
(Fig. 1). Firstly, we made patch-clamp recordings from wild type
HEK cells in order to examine the endogenous currents. We saw
no KCa2-like (voltage-independent) currents but instead saw a
small, voltage-dependent current. This endogenous current has
been studied by Zhu et al. [21] who concluded that it was
predominantly carried by chloride channels. It is therefore,
perhaps not surprising that we found it could not be inhibited
by 10 nM apamin (Fig. 1B, C). To further confirm our finding we
stained cells transiently transfected with GFP and either KCa2.2 or
KCa2.3. As is clear from Fig. 1A, antibody staining is visible only in
transfected cells (i.e. those expressing GFP). Finally, we were
unable to demonstrate any inhibitable binding of
125I-apamin to
wild type HEK cells (Fig. 1D). Taken together, these observations
show that there is no detectable expression of endogenous KCa2
channels in the HEK293 cell line used in the present study.
Binding of
125I-apamin to KCa2.2 channels in intact HEK
293 cells
We began by studying the binding of
125I-apamin to KCa2.2
expressed in HEK 293 cells suspended in a normal physiological
buffer. In order to establish an appropriate incubation time for
these experiments we first measured the kinetics of
125I-apamin
association to KCa2.2 channels. The binding curve (Fig. 2A) was
well fitted by a single exponential, yielding an apparent rate
constant of 0.360.03 min
–1. Thus, to ensure that equilibrium was
reached in subsequent binding experiments, we always incubated
cells and ligand together for a minimum of 10 minutes. Fig. 2B
shows results from a typical KCa2.2 saturation binding experiment
using this 10 minute incubation period. Fitting the Hill equation to
pooled data from five experiments yielded estimates of 91640 pM
and 6.461.3 fmol/10
6 cells for KL and Bmax respectively. The
ability of unlabelled apamin to displace
125I-apamin was also
tested in order to examine the possible influence of iodination on
apamin binding. A typical example of the data obtained is shown
in Fig. 2C. The value of Ki for unlabelled apamin obtained from
competition studies was 10362 pM, similar to the value of KL for
125I-apamin. Thus, in these experiments, there appears to be little
difference between apamin and
125I-apamin in terms of their
ability to bind to the channels.
Figure 1. KCa2 channels are not expressed in wild type HEK 293
cells. A Immunostaining of HEK 293 cells transiently transfected with
GFP and KCa2.2 (a,b,c) or KCa2.3 (d,e,f). GFP expressing cells are visible in
a and d. Comparison with the brightfield images in c and f shows that
only a proportion of the cells were transfected. Staining for KCa2
channels is shown in b and e where a signal is only visible in cells also
expressing GFP. The scale bars indicate 10 mm. B Whole cell currents
from a wild type HEK 293 cell recorded using a calcium containing
internal solution before (&) and after exposure to 10 nM apamin (N).
The endogenous current is not inhibited. C Current voltage relationship
for recordings in B. D Binding of
125I-apamin to wild type, KCa2.2 and
KCa2.3 expressing HEK 293 cells. Cells were incubated with 30 pM
125I
apamin in the absence (T) or presence (N.S.) of 100 nM UCL 1848. There
is no significant binding in wild type cells. In contrast, total binding is
much higher in cells expressing KCa2 expressing cells and is almost
completely inhibited by UCL 1848.
doi:10.1371/journal.pone.0073328.g001
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125I-apamin to KCa2.3 channels in intact HEK
293 cells
We next studied apamin binding to KCa2.3 channels. Again we
began by examining the kinetics of binding to ensure that
appropriate incubation times were used. Figure 3A shows the
results from one such experiment. Again the data fit reasonably
well to a single exponential (with apparent rate constant of
0.260.05 min
–1). Thus, again, a 10 minute incubation period was
appropriate in order to ensure that equilibrium was reached. Data
from our saturation binding experiments with KCa2.3-expressing
HEK cells are shown in Figure 3B. Fitting of these data provided
values of 7116226 pM and 175618 fmol/10
6 cells for KL and
Bmax respectively. This KL value is significantly higher than the
value we obtained for KCa2.2 and of the same order as the IC50
reported for inhibition of KCa2.3 current [11,18]. Finally, we
assessed the ability of unlabelled apamin to inhibit mono-
iodoapamin binding and found a Ki value of 350683 pM
(Fig. 3C). This is lower than the estimate of KL for
125I-apamin,
but within a factor of approximately two, which may reflect either
experimental variability or some modest effect of iodination on
apamin binding.
Inhibition of
125I-apamin binding by other KCa2 channel
modulators
We next examined a range of small molecule blockers of KCa2
channels using the
125I-apamin assay, since these have also been
reported to have a variety of potencies and even to have different
rank orders of selectivity in binding versus block experiments. We
thus examined KCa2.2 and then, in a separate experiment,
KCa2.3, testing inhibition of
125I-apamin binding by UCL 1848,
UCL 1684, dequalinium and gallamine. Inhibition curves for these
compounds are shown in Fig. 4A (KCa2.2) and Fig. 4B (KCa2.3).
Data for inhibition of
125I-apamin binding could be described by
an inhibition curve with a Hill slope of one. Further, within the
margins of error for this experiment, it was clear that specific
binding of apamin could be completely inhibited. The values of KL
estimated above were used to calculate estimates of Ki for the
compounds tested which are summarized in Table 1. The rank
order of potency, apamin , UCL1848. UCL1684. dequali-
nium . gallamine was the same for both KCa2.2 and KCa2.3.
However, all of the compounds showed selectivity for KCa2.2 over
KCa2.3.
Inhibition of KCa2.2 current
The same compounds used in binding studies were next
assessed for their ability to inhibit KCa2.2 current in a whole cell
patch-clamp assay. We were careful to examine block of KCa2.2
current under conditions that were essentially identical to those
used in binding. As illustrated in Fig. 5A, HEK cells expressing
KCa2.2 exhibited robust, time-independent currents which
reversed close to the predicted value of EK (285 mV)
(Fig. 5A,C). In the presence of 10 nM apamin which, based on
our binding experiments should be a near saturating concentra-
tion, this current was much reduced (Fig. 5A, right panel). Further,
the residual current was time-dependent, showed weak outward
rectification and reversed at 240 mV. Thus, following the
addition of 10 nM apamin, the only remaining current appeared
to be the endogenous current (not itself inhibitable by apamin)
(Fig. 5B, Fig. 1C). Thus it appears that apamin causes near-
complete block of KCa2 current in our assay. Indeed, our results
suggest that all of the compounds tested produced .90%
inhibition of KCa2.2 current when applied at sufficiently high
Figure 2. Binding of
125I-apamin to KCa2.2. A Time course of
125I-
apamin binding to HEK 293 cells stably expressing KCa2.2. The y-axis
shows specific binding of
125I-apamin at times indicated on the x-axis.
Each point represents the mean of triplicate observations from a single
experiment. The data are fitted by a single exponential function (solid
line) with an apparent rate constant of 0.360.03 min
–1
. The mean rate
constant from 3 separate experiments was 0.2460.04 min
–1 suggesting
that binding reaches equilibrium well within 10 minutes. B Equilibrium
binding of
125I-apamin to HEK 293 cells stably expressing KCa2.2. The
graph shows total (&) and non-specific (N) binding in the presence of
label. Each point is the mean of triplicate observations from a single
experiment. Combined data yielded estimates of KL and Bmax of
91640 pM and 6.461.3 fmol/10
6 cells (n=3). Solid lines represent a
linear fit (non-specific binding) or a fit using the modified Hill equation
for Btot (see methods). C Inhibition of
125I-mono-iodoapamin binding to
KCa2.2 by unlabelled apamin. Each point is the mean of triplicate
observations from a single experiment. Data were fitted to the Hill
equation (solid line). Estimates of KL from saturation binding
experiments were used to estimate Ki as described in the methods
section and the derived estimates are given in Table 1.
doi:10.1371/journal.pone.0073328.g002
Table 1. Summary of IC50 for inhibition of KCa2 current and Ki
for displacement of mono-iodoapamin in cells expressing
KCa2.2 and KCa2.3.
KCa2.2 KCa2.3
Compound IC50 Ki IC50
a Ki
Apamin 11261p M 1 0 3 61.9 pM 1.460.2 nM 350683 pM
UCL 1848 12562.5 pM 9561.7 pM 2.160.3 nM 6526180 pM
UCL1684 53068 pM 1008622 pM 5.860.3 nM 7.761.6 nM
Dequalinium 420699 nM 9776165 nM 9206140 nM 8656160 nM
Gallamine 760.8 mM2 6 65 mM9 8 60.7 mM7 1 68 mM
aData from Hosseini et al. 2000, using CHO cells.
doi:10.1371/journal.pone.0073328.t001
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equation to the concentration-inhibition curves (Fig. 5C). The
IC50 values are given in Table 1 for comparison with the Ki values
obtained from binding. There is good agreement between the two
datasets.
The effect of changes in ionic composition on channel
block
Given the close correspondence between the potency of apamin
measured by electrophysiological block and ligand binding assays
in identical (physiological) solutions, it seemed important to
understand why such disparate values have been reported in the
literature. One obvious possibility concerns the different compo-
sition of solutions used in previously published binding studies. In
binding experiments on isolated membrane preparations it is
common to use solutions which have low ionic strength and are
free of Ca
2+ and Mg
2+. We therefore examined the effect of
changing our extracellular solution to mimic these differences
(Fig. 6A,B,C,D). In our standard bath solution 100 pM reduced
KCa2.2 current to 5165% of control. In contrast, when the
bathing solution was free of added Ca
2+ and Mg
2+ 100 pM
apamin reduced the KCa2 current to 2060.9% of control
(p=,0.05 compared with standard). When, in addition to
removal of Mg
2+ and Ca
2+, NaCl was replaced by 280 mM
sucrose to mimic even more closely conditions reported in the
literature, 100 pM apamin reduced KCa2.2 current to 1567% of
control (p,0.05 compared with standard solution). The effect of
removing Ca
2+ and Mg
2+ was further examined by constructing a
concentration-inhibition curve for apamin in Mg
2+ and Ca
2+ free
conditions (Fig. 6E). The IC50 and Hill slope were 2063 pM and
0.860.06 respectively. Thus, simply removing divalent cations
from the bath solution caused an approximately 5-fold increase in
potency. These results suggest that the potency of apamin in
binding to KCa2.2 channels is increased under ionic conditions
similar to those frequently used in binding assays. This may
account for a substantial part of the very high affinity KL and Ki
values of apamin binding in previously published data.
Discussion
Binding and block for apamin
We find that when apamin binding and apamin block of KCa2
channels are measured using the same ionic conditions, the values
of Ki and KL for binding and the value of IC50 for inhibition (block)
of current agree well. Whilst previous reports in the literature
found differences of up ,20–200-fold, the largest discrepancy we
found in comparing binding and block for both KCa2.2 and
Figure 3. Binding of
125I-apamin to KCa2.3. A Time course of
125I-
apamin binding to HEK 293 cells stably expressing KCa2.3. The y axis
shows specific binding of
125I-apamin at times indicated on the x-axis.
Each point represents the mean of triplicate observations from a single
experiment. The data are fitted by a single exponential function (solid
line) with a rate constant of 0.260.05 min
–1
, suggesting binding
reaches equilibrium within 10 minutes. B Equilibrium binding of
125I-
apamin to HEK 293 cells stably expressing KCa2.3. The graph shows total
(&) and non-specific (N) binding in the presence of label. Each point is
the mean of triplicate observations from a single experiment. Combined
data yielded estimates of KL and Bmax of 7116226 pM and
175618 fmol/10
6 cells. Solid lines represent a linear fit (non-specific
binding) or a fit using the modified Hill equation for Btot (see methods).
C Inhibition of
125I-apamin binding to KCa2.3 by unlabelled apamin.
Each point is the mean of triplicate observations from a single
experiment. Data were fitted to the Hill equation (solid line). Estimates
of KL from saturation binding experiments were used to estimate Ki as
described in the methods section and the derived values are given in
Table 1.
doi:10.1371/journal.pone.0073328.g003
Figure 4. Inhibition of
125I-apamin binding to KCa2.2 and 2.3 by
known KCa2 inhibitors. Inhibition of
125I-apamin binding to KCa2.2(A)
and KCa2.3(B) by the known KCa2 blockers UCL 1848 (m), UCL 1684 (N),
dequalinium (&) and gallamine (.). Each point is the mean of triplicate
observations from a single experiment. Data were fitted to the Hill
equation (solid lines) and the values of IC50 used to estimate Ki as
described in Methods. The pooled data are shown in Table 1.
doi:10.1371/journal.pone.0073328.g004
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case the comparison is to IC50 values using a different cell line
(CHO cells) in a study that was not part of the current work.
Further, the IC50 values we observed are, overall, very similar to
the values obtained by others using electrophysiological approach-
es to measure inhibition [11,13,15,17,22]. In contrast, previously
published values of KL for the binding of labelled apamin to
membrane preparations of KCa2.2-expressing HEK cells have
been much lower, of the order of 6 pM [16,17]. Moreover, whilst
it is often reported that apamin is significantly more potent as a
blocker of KCa2.2 than KCa2.3 (see e.g. Kohler et al.[11]) binding
studies on isolated membranes suggest that apamin does not
discriminate between the two sub-types [16,17]. In the present
study we found that labelled apamin bound to KCa2.3 with a KL of
7116226 pM and a Ki value of 350683 pM. Even taking the
lowest of these estimates the affinity of apamin is still significantly
less for KCa2.3 than KCa2.2 (KL 90640 pM, Ki 10362 pM). This
is in keeping with IC50 values from functional experiments (see
Table 1).
Other evidence supports our conclusion that the ionic
conditions used in binding measurements markedly affect the
outcome. For example, in intact guinea pig hepatocytes the KL for
apamin binding in normal physiological solutions was reported as
390 pM [6], of the same order as the concentration needed to
cause 50% block in functional experiments. In marked contrast, a
value of 3 pM was reported for binding to hepatocyte membranes,
an experiment performed in low ionic strength [23]. Similarly, in
primary cultures of intact cortical neurones a value of 60 to
120 pM was reported by Seagar et al. [24] in normal physiological
solutions, compared with a value of 6 pM for isolated cortical
membranes, again at low ionic strength [16]. Finally, Hugues et al.
[5] reported a similar discrepancy between binding of labelled
apamin to, and inhibition of, the apamin-sensitive AHP in NIE115
neuroblastoma cells. Further work by this group showed that the
binding of labelled apamin was inhibited by divalent cations
including Mg
2+ and Ca
2+ and by Na
+. In keeping with this
observation we have now demonstrated that removal of Ca
2+ and
Mg
2+ caused an increase in the blocking action of apamin. In
experiments on isolated membranes it is standard practice to use a
low ionic strength solution (e.g., 10 mM Tris, 5.4 mM KCl, pH
7.5 as employed by Lamy et al. [17]. Taken together, the evidence
now available suggests that ionic environment is highly important
in determining the affinity of apamin for its binding site. Whether
Figure 5. Effects of apamin and known KCa2 inhibitors on
KCa2.2 current. A Typical current record from a HEK 293 cell
transiently transfected with KCa2.2. In control solution (left panel)
robust, time-independent currents are seen. Application of 10 nM
apamin causes a very substantial reduction (right panel). B Current
voltage relationships for the cell in A in the absence (&) and presence
(N) of 10 nM apamin. In the absence of apamin the current reverses at
280 mV, close to the predicted value of EK. In the presence of apamin
the residual current is similar to that seen in an untransfected HEK 293
cell (#) suggesting that at this concentration apamin causes nearly
complete inhibition of KCa2 current. C Concentration inhibition curves
for apamin (N), UCL 1848 (%), UCL 1684 (m), dequalinium (X) and
gallamine (.). Each point is the mean of 3–5 observations, vertical bars
show s.e.m. Fitted lines were drawn from the Hill equation with a
common Hill slope of 0.760.04 (see Methods). Note that the curves
drawn for apamin and UCL 1848 overlie each other. At sufficiently high
concentrations of blocker near complete inhibition of current is
achieved. The IC50 values calculated for each compound are given in
Table 1.
doi:10.1371/journal.pone.0073328.g005
Figure 6. The effect of the ionic composition of bathing
solution on the potency of apamin. Representative recordings of
KCa2 current in HEK 293 cells transiently transfected with KCa2.2. The
recordings were made in standard solution (A), nominally Ca
2+ and
Mg
2+ free solution (B) and Na
+,M g
2+ and Ca
2+ free solution in which
NaCl was replaced by 280 mM sucrose (C). In each case the left panel
shows currents recorded before and the right panel after the
application of 100 pM apamin. D Summary of data for the inhibition
caused by 100 pM apamin in the solutions used in A, B and C. Vertical
bars show s.e.m. * denotes that the values were significantly different
from the effect of apamin in standard solution (p,0.05, unpaired t-test).
E Concentration-inhibition curve for apamin applied in Ca
2+ and Mg
2+
free solution. Each point is the mean of 3–5 observations with vertical
bars indicating s.e.m. The solid line was drawn from a fit of the Hill
equation with IC50=2 0 63 pM and n=0.860.06. The dashed line
represents the concentration-inhibition curve for apamin in standard
solution shown in Figure 4.
doi:10.1371/journal.pone.0073328.g006
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toxin interaction remains to be determined. Nor is it possible to
exclude the possibility that the conformation and charge
distribution in apamin itself changes in a low ionic strength
solution devoid of Ca
2+,M g
2+ and Na
+. It is interesting in relation
to this to note that binding/action discrepancy seen under such
experimental conditions is not observed with all blockers e.g. UCL
1684 [25], even though this compound carries two positive charges
to mimic the charges that are thought to be important in apamin
binding.
It is also interesting to compare the values of KL for the binding
of apamin obtained in this study with values for the IC50 obtained
in preparations natively expressing KCa2 channels of known
subtype. KCa2.2 has been shown to underlie the Ca
2+-activated K
+
current seen in Jurkat T cells [26] and these native channels are
blocked by apamin with an IC50 of 300 pM [27], a value that is
much higher than would be expected from membrane binding
experiments performed in non-physiological ionic conditions.
Similarly, rat sympathetic ganglion neurones and dorsal vagal
neurones display a post-spike after-hyperpolarisation which is
known to be mediated by KCa2.3 and is inhibited by apamin with
an IC50 of ,2 nM [18,28], again a value that is much higher than
expected from binding studies of isolated membranes. However, in
both of these cases the values are similar to those obtained from
functional studies of heterologously expressed channels and from
the values of KL obtained in binding experiments (using
physiological solutions) in the present study. Further, looking at
the different values for native KCa2.2 and KCa2.3 channels it
appears that subtype selectivity is also observed in this setting and
may thus be useful for elucidating the function of KCa2 channels
in the future.
Investigation of KCa2 pharmacology by ligand binding
and electrophysiology
We also compared the potency of some known KCa2 channel
blockers in electrophysiological and binding inhibition experi-
ments. With cells expressing KCa2.2 there was good agreement
between Ki and IC50 values for all the compounds tested
(UCL1848, UCL 1684, dequalinium and gallamine; Table 1).
The largest difference between Ki and IC50 was a factor 3.7 for
gallamine, the least active of the set and therefore the most likely to
show non-specific actions. Similar agreement was seen with
KCa2.3 (Table 1). The implication is that provided the binding
studies are done using bathing fluids with ionic composition not far
removed from physiological, they can give a good prediction of
biological activity.
Implications for interpreting the mechanism of apamin
block of KCa2 channels
Early experiments suggested that apamin might simply act as a
pore blocker for KCa2 channels because TEA (a known small
molecule pore blocker), prevented the binding of apamin [16,29].
Nonetheless, mutation studies have shown that interactions of
apamin with the channel involve a number of amino acid residues,
some of which are outside the central pore region [22,30,31]. This
and other evidence has led to the suggestion that apamin does not
act as a ‘classical’ pore blocker but instead inhibits channel
opening by an allosteric mechanism [17,32]. The discrepancy
between the KL for binding of apamin (measured in low ionic
strength) and IC50 for inhibition of KCa2.2 current (measured in
normal physiological solutions) has been cited as evidence in
support of this idea. Our findings suggest that caution must be
exercised when making this kind of comparison. In particular, it is
clear that ligand binding experiments agree much more closely
with functional experiments when conducted under identical
physiological conditions. Of course, agreement between IC50 and
Ki values does not exclude an allosteric mode of action and indeed
it is quite difficult to imagine an allosteric mechanism that does not
predict close accord in the concentration dependence of both
binding and block (otherwise block would still be able to increase
when binding had already saturated). On the other hand, some
allosteric mechanisms would predict incomplete block of current
even at high concentrations of apamin. We see no clear evidence
of this, in keeping with a number of other reports [11,13,22].
Nonetheless, two groups do report partial block [17,33] so that
more work is needed to clarify this aspect of the action of apamin.
In summary, we have found that there is a close relationship
between the binding and block of KCa2 channels for both apamin
and other small molecule blockers when these are measured under
identical conditions. While this observation is consistent with both
allosteric and non-allosteric models it suggests that caution must be
exercised when comparing electrophysiological block data ob-
tained in normal (physiological) conditions with binding data
obtained in non-physiological conditions. Our findings also suggest
that more work may be needed to establish precisely the
mechanism of action of apamin and other compounds known to
block KCa2 channels.
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